Revvity reported $111.8M in Ordinary Share Capital for its fiscal quarter ending in March of 2026.





Ordinary Share Capital Change Date
Agilent USD 282.22M 478K Mar/2026
Align Technology USD 71.62M 133K Mar/2026
Bio Techne USD 156.45M 703K Mar/2026
Bio-Rad Laboratories USD 26.99M 18K Dec/2025
Bruker USD 152.22M 282K Mar/2026
Celltrion KRW 218.61M 162.21K Dec/2025
Charles River Laboratories USD 48.17M 1.05M Mar/2026
Cspc Pharmaceutical CNY 11.52B 3.7M Dec/2025
Danaher USD 707.7M 800K Mar/2026
Dentsply International USD 200.3M 700K Mar/2026
Deva Holding AS TRY 200.02M 0 Sep/2023
Dianthus Therapeutics USD 43.22M 368.53K Dec/2025
Divis Laboratories Ltd INR 265.47M 0 Mar/2026
Edwards Lifesciences USD 580.7M 0 Dec/2025
Illumina USD 151.91M 893K Mar/2026
Intuitive Surgical USD 355.17M 674K Mar/2026
IQVIA Holdings USD 166.9M 2.7M Mar/2026
Kangmei Pharma CNY 13.83B 0 Mar/2026
Knight Therapeutics CAD 99.68M 24.66K Sep/2025
Laboratorios Farma EUR 51.82M 1.55M Dec/2023
Laboratory Of America USD 82.3M 100K Mar/2026
Malin Corporation EUR 200K 0 Dec/2024
Medical Developments International AUD 112.66M 2.35M Dec/2025
Mesa Laboratories USD 349.53M 3.53M Sep/2024
Mettler Toledo International USD 20.25M 179.94K Mar/2026
Myriad Genetics USD 93.5M 400K Dec/2025
Neuren Pharmaceuticals AUD 126.64M 38.63M Dec/2025
OraSure Technologies USD 70.39M 1.87M Dec/2025
Organigram Holdings CAD 135.13M 671.75K Dec/2025
Ovoca Bio EUR 29.49M 18.43M Jun/2025
Pacific Biosciences Of California USD 301.96M 103K Dec/2025
Pharma Mar EUR 17.36M 0 Mar/2026
Qiagen NV USD 216.56M 284.67K Dec/2025
Quest Diagnostics USD 111M 1000K Mar/2026
Quidel USD 67.9M 0 Dec/2025
Repligen USD 56.4M 74K Mar/2026
Revvity USD 111.8M 1.57M Mar/2026
Sartorius EUR 69.05M 0 Mar/2026
Sino Biopharmaceutical CNY 17.89B 30.5M Jun/2025
Thermo Fisher Scientific USD 371.62M 4.09M Mar/2026
Tilray USD 116.52M 5.01M Sep/2025
Waters USD 98.17M 89K Mar/2026
Zealand Pharma A/S 70.61M 319.68K Dec/2025
Zz Pientze Pharmaceu CNY 603.32M 0 Mar/2026